TFRC and breast carcinoma: Notably, breast cancer shows both elevated levels of TFR and decreased levels of the iron exporter ferroportin 1 (FPN1), both in breast cancer tissue and cancer cell lines with a higher malignancy potential, denoting an iron-reserving phenotype, compatible with their increased proliferative status [2].